drugset / Trial / NCT05348278

Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome

NCT05348278

Phase 2/3 Unknown 214 enrolled Mahidol University Siriraj Hospital · collab
RandomizedParallel-groupSingle-blindPrevention

Summary

Hand foot skin reaction (HFS) from capecitabine is one of the most common adverse events from capecitabine. Urea cream has been proved its benefit to prevent HFS from sorafenib. Prior study using urea cream prophylaxis in patients receiving capecitabine was negative. However, result from aformentioned study was reported primarily from result of first cycle capecitabine. Urea cream as a prevention of HFS from capecitabine has been used in clinical practice in Thailand according to expert's opinion. We conducted the study to evaluate wheter the urea cream can prevent HFS or severe HFS.

Timeline

Start
2021-12-20
Primary completion
2023-05
Completion
2023-08

Drugs

EvaluationDrugModalityDoseRoute
Subject urea Unknown 10 % Topical

Indications